Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Pharma Industry Analysis

UpdatedAug 10, 2025
DataAggregated Company Financials
Companies293
  • 7D-5.3%
  • 3M-3.6%
  • 1Y-16.1%
  • YTD-8.2%

Over the last 7 days, the Pharma industry has dropped 5.3%, driven by Eli Lilly declining 18%. The industry has fallen 16% in the last year. Earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the U.S. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Aug 2025US$1.6tUS$387.9bUS$60.7b18.4x27x4.2x
Tue, 08 Jul 2025US$1.7tUS$382.7bUS$61.3b18.1x28.5x4.6x
Thu, 05 Jun 2025US$1.7tUS$382.7bUS$61.2b17.9x27.7x4.4x
Sat, 03 May 2025US$1.7tUS$382.7bUS$63.7b17.2x27.3x4.5x
Mon, 31 Mar 2025US$1.8tUS$380.6bUS$41.3b15.8x44.8x4.9x
Wed, 26 Feb 2025US$1.9tUS$381.1bUS$39.2b18.2x48.9x5x
Fri, 24 Jan 2025US$1.8tUS$370.4bUS$30.5b18.4x57.9x4.8x
Sun, 22 Dec 2024US$1.8tUS$369.4bUS$31.1b16.7x57.2x4.8x
Tue, 19 Nov 2024US$1.8tUS$373.9bUS$30.5b19x58.5x4.8x
Thu, 17 Oct 2024US$2.0tUS$365.3bUS$23.7b18.8x85.8x5.6x
Sat, 14 Sep 2024US$2.0tUS$364.2bUS$25.5b18.8x80.1x5.6x
Mon, 12 Aug 2024US$2.0tUS$362.1bUS$22.0b16.7x89.6x5.4x
Wed, 10 Jul 2024US$2.0tUS$357.6bUS$13.8b15.4x141.9x5.5x
Fri, 07 Jun 2024US$1.9tUS$358.3bUS$14.1b15.5x135.6x5.3x
Sun, 05 May 2024US$1.8tUS$358.0bUS$13.8b21.4x131.1x5.1x
Tue, 02 Apr 2024US$1.9tUS$355.2bUS$22.7b22.5x84.2x5.4x
Thu, 29 Feb 2024US$1.9tUS$355.1bUS$23.8b24.3x80x5.4x
Sat, 27 Jan 2024US$1.8tUS$375.2bUS$33.9b24.6x51.6x4.7x
Mon, 25 Dec 2023US$1.7tUS$375.1bUS$33.9b32x49.3x4.4x
Wed, 22 Nov 2023US$1.6tUS$375.1bUS$33.9b25.8x48.1x4.4x
Fri, 20 Oct 2023US$1.7tUS$382.7bUS$44.7b17.6x37x4.3x
Sun, 17 Sep 2023US$1.7tUS$381.8bUS$43.9b18x39.2x4.5x
Tue, 15 Aug 2023US$1.8tUS$381.5bUS$43.8b19x40.5x4.7x
Thu, 13 Jul 2023US$1.7tUS$392.8bUS$60.2b18.2x27.5x4.2x
Sat, 10 Jun 2023US$1.7tUS$393.0bUS$60.5b18.6x28.4x4.4x
Mon, 08 May 2023US$1.7tUS$393.0bUS$59.5b19.4x28.9x4.4x
Wed, 05 Apr 2023US$1.6tUS$401.2bUS$69.4b15.6x23.1x4x
Fri, 03 Mar 2023US$1.6tUS$401.3bUS$69.6b18.3x22.3x3.9x
Sun, 29 Jan 2023US$1.7tUS$402.6bUS$69.4b17.7x24x4.1x
Tue, 27 Dec 2022US$1.8tUS$403.7bUS$70.7b16.8x24.8x4.4x
Thu, 24 Nov 2022US$1.7tUS$403.7bUS$70.7b15.4x24.6x4.3x
Sat, 22 Oct 2022US$1.6tUS$403.4bUS$72.1b13.2x22.5x4x
Mon, 19 Sep 2022US$1.6tUS$403.0bUS$71.3b13.8x22.3x3.9x
Wed, 17 Aug 2022US$1.7tUS$403.0bUS$70.0b15.1x23.6x4.1x
Price to Earnings Ratio

23.6x


Total Market Cap: US$1.7tTotal Earnings: US$70.0bTotal Revenue: US$403.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Pharma Industry Price to Earnings3Y Average 52.1x202320242025
Current Industry PE
  • Investors are pessimistic on the American Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 27.0x which is lower than its 3-year average PE of 52.1x.
  • The industry is trading close to its 3-year average PS ratio of 4.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 4.6% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market2.39%
Healthcare-0.91%
Pharma-5.30%
Pharma-5.30%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
JNJ Johnson & JohnsonUS$173.333.6%
+US$14.5b		7.9%PE18.4x
PFE PfizerUS$24.584.6%
+US$6.2b		-13.9%PE13x
BMY Bristol-Myers SquibbUS$45.953.9%
+US$3.5b		-1.6%PE18.5x
MRK MerckUS$80.691.8%
+US$2.4b		-29.6%PE12.3x
ELAN Elanco Animal HealthUS$16.6720.9%
+US$1.4b		27.8%PE19.1x

Latest News

JAZZ
US$111.30
Jazz Pharmaceuticals
7D
-3.7%
1Y
-0.06%

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
RPRX
US$37.58
Royalty Pharma
7D
1.3%
1Y
43.1%
ELAN
US$16.67
Elanco Animal Health
7D
20.9%
1Y
27.8%
LLY
US$625.65
Eli Lilly
7D
-17.9%
1Y
-29.8%
PBH
US$65.58
Prestige Consumer Healthcare
7D
-11.0%
1Y
-1.0%
VTRS
US$9.70
Viatris
7D
10.1%
1Y
-17.7%
PRGO
US$22.55
Perrigo
7D
-15.4%
1Y
-16.2%
TEVA
US$16.37
Teva Pharmaceutical Industries
7D
6.4%
1Y
-6.1%
EOLS
US$5.90
Evolus
7D
-35.5%
1Y
-54.5%
PFE
US$24.58
Pfizer
7D
4.6%
1Y
-13.9%
ZTS
US$147.35
Zoetis
7D
-0.02%
1Y
-20.5%
BMY
US$45.95
Bristol-Myers Squibb
7D
3.9%
1Y
-1.6%
EWTX
US$12.68
Edgewise Therapeutics
7D
-11.4%
1Y
-22.9%
JNJ
US$173.33
Johnson & Johnson
7D
3.6%
1Y
7.9%
MRK
US$80.69
Merck
7D
1.8%
1Y
-29.6%
BGM
US$7.70
BGM Group
7D
-10.5%
1Y
n/a